Balance Sheets (Current Period Unaudited) - USD ($)	Jun. 30, 2020	Dec. 31, 2019
Assets
Cash and cash equivalents	$ 172,802	$ 409,039
Accounts receivable	751
Inventory	3,675	4,131
Prepaid expense and other current assets	14,583	32,125
Total current assets	191,811	445,295
Patents, net	141,257	146,263
Property and equipment, net	3,904	5,068
Total assets	336,972	596,626
Liabilities and Stockholders' Equity (Deficit)
Accounts payable and accrued expenses	292,241	208,727
Advances from investors	10,000	100,000
Convertible notes payable – related party	578,664	444,581
Total current liabilities	880,905	753,308
Total liabilities	880,905	753,308
Stockholders' equity (deficit)
Authorized shares - 10,000,000, Issued and outstanding shares – 0 at June 30, 2020 and December 31, 2019
Common stock, $0.01 par value: Authorized shares - 100,000,000, Issued and outstanding shares –40,916,351 and 40,516,351 at June 30, 2020 and December 31, 2019, respectively	409,164	405,164
Additional paid-in capital	4,495,380	4,207,786
Accumulated deficit	(5,448,477)	(4,769,632)
Total stockholders’ equity (deficit)	(543,933)	(156,682)
Total liabilities and stockholders’ equity (deficit)	$ 336,972	$ 596,626